Skip to main content

B. Metzler seel. Sohn & Co. AG

Position in NBIX — Neurocrine Biosciences Inc

CIK 1847838 FRANKFURT, 2M

Position in NBIX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$785,433
+$113,586 QoQ
Shares Held
5,962
+25.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 58% Shared 0% None 42%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

B. Metzler seel. Sohn & Co. AG holds $26,269,777 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
5,962 $785,433

All Filings in NBIX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $785,433 5,962
2025-12-31 $671,847 4,737
2025-09-30 $752,296 5,359
2025-06-30 $673,572 5,359
2025-03-31 $547,359 4,949
2024-12-31 $688,506 5,044
2024-09-30 $552,940 4,799
2024-06-30 $346,790 2,519
2024-03-31 $330,732 2,398
2023-12-31 $257,327 1,953
2023-09-30 $486,337 4,323
2022-12-31 $233,266 1,953